From Evidence Strategy
to Patient Access
Senior Market Access, HEOR &
HTA Advisory
Professional consulting to the pharmaceutical and biotech industries,
ensuring successful value demonstration and global market access
25+
Years of Industry Experience
120+
Access & HTA Projects
30+
Global Markets Supported
Strategic Advisory for Access-Critical Decisions
Strategic and operational advisory for pharmaceutical and biotech organisations. I help clients demonstrate the value of their medicines and navigate complex HTA and reimbursement pathways to achieve successful global market access.
Trusted by leaders across pharma and biotech, with experience spanning Astellas, Teva, Boehringer-Ingelheim and emerging biotech organisations.
